Evaluation of long term tobramycin thera
β
U. Paporisz; H. G. Posselt; R. WΓΆnne; W. Ristow; D. RΓΆser; H. Knothe; S. W. Bend
π
Article
π
1979
π
Springer
π
English
β 493 KB
To nine cystic fibrosis patients with chronic bronchopulmonary infection of severely damaged lungs invaded by Pseudomonas aeruginosa, eleven courses of prolonged tobramycin treatment (5 mg/kg/day) for four to 16 weeks were administered. Pulmonary symptoms improved and a better quality of life was ac